Healthcare / Obesity Treatment
Wave Life Sciences Plunges After Obesity Data
Wave Life Sciences (WVE) stock plummeted after the release of interim data from an early-stage trial of its RNA-based obesity medicine, WVE-007. The trial data, focusing on healthy individuals, led to a sharp negative reaction from Wall Str...